{"id":15590,"date":"2021-10-29T15:35:26","date_gmt":"2021-10-29T19:35:26","guid":{"rendered":"https:\/\/arsacs.com\/?p=15590"},"modified":"2026-03-16T18:13:31","modified_gmt":"2026-03-16T22:13:31","slug":"exploring-the-role-of-genetic-and-epigenetic-modifiers-in-modifiers-in-arsacs-dr-daniele-galatolo-2","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/exploring-the-role-of-genetic-and-epigenetic-modifiers-in-modifiers-in-arsacs-dr-daniele-galatolo-2\/","title":{"rendered":"\u201cExploring the role of genetic and epigenetic modifiers in modifiers in ARSACS\u201d &#8211; Dr. Daniele Galatolo"},"content":{"rendered":"<em>\u00a0<\/em>\n\nThe overall aim of this research is to identify the potential co-occurrence of genomic variants beyond mutations in the <em>SACS<\/em> gene and the epigenetic effects that might explain the different phenotype severity existing among ARSACS patients.\n\nGrant: $52,000\n\nDuration : one year\n\nContact:\n\n<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-15770 alignleft\" src=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/10\/Daniele-Galatolo-photo-201x300.jpg\" alt=\"\" width=\"155\" height=\"231\" srcset=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/10\/Daniele-Galatolo-photo-201x300.jpg 201w, https:\/\/arsacs.com\/wp-content\/uploads\/2021\/10\/Daniele-Galatolo-photo.jpg 408w\" sizes=\"(max-width: 155px) 100vw, 155px\" \/>\n\nDr. Daniele Galatolo\n\nMolecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit\n\nIRCCS Stella Maris Foundation\n\nvia dei Giacinti 2,\n\n56128 Calambrone (Pisa) - Italy\n\nemail : daniele.galatolo@fsm.unipi.it","protected":false},"excerpt":{"rendered":"<p>\u00a0 The overall aim of this research is to identify the potential co-occurrence of genomic variants beyond mutations in the SACS gene and the epigenetic effects that might explain the different phenotype severity existing among ARSACS patients. Grant: $52,000 Duration : one year Contact: Dr. Daniele Galatolo Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[],"class_list":["post-15590","post","type-post","status-publish","format-standard","hentry","category-research-in-2021"],"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/15590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=15590"}],"version-history":[{"count":12,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/15590\/revisions"}],"predecessor-version":[{"id":24744,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/15590\/revisions\/24744"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=15590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=15590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=15590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}